Surface Oncology - Stock Price History | SURF

Historical daily share price chart and data for Surface Oncology since 2020 adjusted for splits. The latest closing stock price for Surface Oncology as of February 28, 2020 is 3.16.
  • The all-time high Surface Oncology stock closing price was 17.83 on July 09, 2018.
  • The Surface Oncology 52-week high stock price is 5.45, which is 72.5% above the current share price.
  • The Surface Oncology 52-week low stock price is 1.15, which is 63.6% below the current share price.
  • The average Surface Oncology stock price for the last 52 weeks is 2.80.
Surface Oncology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.1640 4.3500 5.8800 1.1700 1.8800 -55.66%
2018 11.0885 13.3300 17.8300 3.6500 4.2400 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.074B $0.059B
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $139.646B 24.44
Medtronic (MDT) Ireland $135.351B 18.19
Stryker (SYK) United States $72.986B 23.59
Boston Scientific (BSX) United States $52.944B 23.85
Baxter (BAX) United States $43.025B 26.09
Lonza Group Ag (LZAGY) Switzerland $30.160B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.680B 0.00
Coloplast (CLPBY) Denmark $29.333B 45.27
Zimmer Biomet Holdings (ZBH) United States $28.886B 17.78
Terumo (TRUMY) Japan $24.016B 29.97
ResMed (RMD) United States $23.532B 40.88
Smith & Nephew SNATS (SNN) United Kingdom $20.258B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.551B 706.73
Bio-Rad Laboratories (BIO) United States $10.800B 50.46
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Perrigo (PRGO) Ireland $7.053B 12.86
Hill-Rom Holdings (HRC) United States $6.647B 19.12
DiaSorin S.p.A (DSRLF) Italy $6.446B 0.00
Canopy Growth (CGC) Canada $6.442B 0.00
Haemonetics (HAE) United States $5.501B 33.86
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.142B 27.18
Envista Holdings (NVST) United States $4.140B 0.00
NuVasive (NUVA) United States $3.433B 26.54
Neogen (NEOG) United States $3.353B 55.81
Quidel (QDEL) United States $3.229B 28.35
GW Pharmaceuticals (GWPH) United Kingdom $3.227B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.121B 0.00
Agios Pharmaceuticals (AGIO) United States $3.055B 0.00
National Vision Holdings (EYE) United States $2.822B 47.54
Aurora Cannabis (ACB) Canada $1.695B 0.00
AtriCure (ATRC) United States $1.602B 0.00
Cardiovascular Systems (CSII) United States $1.335B 0.00
NanoString Technologies (NSTG) United States $1.282B 0.00
TG Therapeutics (TGTX) United States $1.235B 0.00
InMode (INMD) Israel $1.053B 0.00
Phibro Animal Health (PAHC) United States $1.038B 20.54
Aphria (APHA) $0.934B 0.00
VAREX IMAGING (VREX) United States $0.909B 18.88
PetIQ (PETQ) United States $0.899B 21.94
Cerus (CERS) United States $0.840B 0.00
Quanterix (QTRX) United States $0.665B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.662B 126.31
Eagle Pharmaceuticals (EGRX) United States $0.642B 24.57
Lantheus Holdings (LNTH) United States $0.614B 13.96
LeMaitre Vascular (LMAT) United States $0.594B 33.79
Omeros (OMER) United States $0.591B 0.00
MacroGenics (MGNX) United States $0.496B 0.00
Surmodics (SRDX) United States $0.481B 55.34
Zynex (ZYXI) United States $0.390B 42.57
Owens & Minor (OMI) United States $0.385B 14.26
OraSure Technologies (OSUR) United States $0.370B 46.15
Organigram Holdings (OGI) Canada $0.363B 0.00
Repro-Med Systems (KRMD) United States $0.356B 225.00
Meridian Bioscience (VIVO) United States $0.349B 14.07
HEXO (HEXO) $0.335B 0.00
Utah Medical Products (UTMD) United States $0.335B 23.82
BioLife Solutions (BLFS) United States $0.298B 121.58
Evolus (EOLS) United States $0.288B 0.00
Female Health (VERU) United States $0.278B 0.00
Bovie Medical (APYX) United States $0.226B 0.00
InfuSystems Holdings (INFU) United States $0.206B 1037.00
Vapotherm (VAPO) United States $0.193B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.191B 0.00
Viemed Healthcare (VMD) United States $0.190B 20.00
Rockwell Medical (RMTI) United States $0.187B 0.00
United Health Products (UEEC) United States $0.176B 0.00
Cytosorbents (CTSO) United States $0.170B 0.00
Fonar (FONR) United States $0.132B 9.58
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.107B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
United-Guardian (UG) United States $0.074B 18.60
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
Nephros (NEPH) United States $0.066B 0.00
FSD PHARMA INC (HUGE) Canada $0.040B 0.00
NF Energy Saving (BIMI) China $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
Trinity Biotech (TRIB) Ireland $0.026B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Myomo (MYO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00